Compounding Chief Departing US FDA After Leading Office Through 'Tumultuous Times'

Julie Dohm, who led a wide range of initiatives to bolster FDA's oversight of compounding pharmacies, will be joining Covington & Burling after leaving the agency March 29. A replacement has not yet been announced.